Connection
Kristina Brooks to Double-Blind Method
This is a "connection" page, showing publications Kristina Brooks has written about Double-Blind Method.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.065 |
|
|
|
-
Vyshenska D, Reed JC, Roychoudhury P, Zheng L, Olefsky M, Ritz J, McCarthy C, Saha PT, Hao L, Mills MG, Shea A, Nunley BE, Javan AC, Brooks KM, Nachman S, Eron J, Gandhi RT, Currier J, Fischer WA, Zucker J, Wilkin T, Greninger AL. Tecovirimat treatment of clade II mpox: a virological analysis of a randomised, double-blind, phase 3 trial. Lancet Microbe. 2026 Sep; 7(9):101464.
Score: 0.042
-
Beigel JH, Voell J, Muñoz P, Kumar P, Brooks KM, Zhang J, Iversen P, Heald A, Wong M, Davey RT. Safety, tolerability, and pharmacokinetics of radavirsen (AVI-7100), an antisense oligonucleotide targeting influenza a M1/M2 translation. Br J Clin Pharmacol. 2018 Jan; 84(1):25-34.
Score: 0.023
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|